2m 2m 2m 2m 2m 2m 2m
MAPLIGHT THERAPE (MPLT)
NASDAQ
$28.31-$0.04 (-0.12%)
Price as of Jun 03, 2026 4:48 PM EDT- $1.2BMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
MAPLIGHT THERAPE (MPLT)
$28.31-$0.04 (-0.12%)
MPLT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.34 | ||
Change | -$2.42 (-8.13%) | ||
Open | $27.26 | ||
High | $28.37 | ||
Low | $25.66 | ||
Previous Close | $27.34 | ||
Volume | 193,208 | ||
30-Day Average Volume | 279,162 | ||
1-Week Change | -7.20% | ||
1-Month Change | -10.94% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 42.6M | ||
Total Assets | $418.8M | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$60.7M | ||
Free Cash Flow | -$51.2M | ||
EBIT | -$60.7M | ||
EBITDA | -$60.5M | ||
Net Working Capital | N/A | ||
EPS | -$1.34 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -22 | ||
PEG | -0 | ||
Price/Free Cash Flow | -24 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue